Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Brendan Hannah currently holds 365,000 shares of Quince Therapeutics, Inc. (QNCX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brendan Hannah has been a net buyer of QNCX stock. They have purchased $111.7K and sold $0 worth of shares.
Brendan Hannah's most recent insider trade was on Jan 23, 2026, when they sold 365,000 shares at $0.00 per share.
Brendan Hannah serves as Executive at Quince Therapeutics, Inc. (QNCX). They have executed 15 insider transactions totaling $111.7K over their tenure at the company.
Brendan Hannah holds the position of Executive at Quince Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Brendan Hannah has shown a buying trading pattern, with $111.7K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Brendan Hannah was on Aug 8, 2023, when they purchased $87.5K worth of QNCX shares. This transaction involved 71,762 shares at $1.22 per share.
Brendan Hannah currently owns 365,000 shares of Quince Therapeutics, Inc. (QNCX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Brendan Hannah's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Brendan Hannah has 15 Form 4 filings on record as an insider at Quince Therapeutics, Inc..
Set alerts for Brendan Hannah and 40,000+ other insiders.